Integrated Wealth Concepts LLC Sells 1,185 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Integrated Wealth Concepts LLC decreased its stake in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 6.7% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 16,390 shares of the company’s stock after selling 1,185 shares during the period. Integrated Wealth Concepts LLC’s holdings in SPDR S&P Pharmaceuticals ETF were worth $727,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets lifted its holdings in SPDR S&P Pharmaceuticals ETF by 208.6% during the 3rd quarter. BNP Paribas Financial Markets now owns 149,419 shares of the company’s stock worth $6,628,000 after buying an additional 101,000 shares in the last quarter. First Citizens Bank & Trust Co. lifted its stake in shares of SPDR S&P Pharmaceuticals ETF by 9.5% during the third quarter. First Citizens Bank & Trust Co. now owns 72,053 shares of the company’s stock valued at $3,196,000 after acquiring an additional 6,227 shares during the period. AlphaMark Advisors LLC lifted its stake in shares of SPDR S&P Pharmaceuticals ETF by 5.9% during the third quarter. AlphaMark Advisors LLC now owns 6,225 shares of the company’s stock valued at $276,000 after acquiring an additional 348 shares during the period. Rockport Wealth LLC acquired a new stake in SPDR S&P Pharmaceuticals ETF in the second quarter worth about $1,813,000. Finally, Angeles Wealth Management LLC bought a new stake in SPDR S&P Pharmaceuticals ETF during the 2nd quarter worth about $40,000.

SPDR S&P Pharmaceuticals ETF Trading Down 0.8 %

SPDR S&P Pharmaceuticals ETF stock opened at $45.77 on Tuesday. The company has a market cap of $221.98 million, a PE ratio of 14.39 and a beta of 0.87. SPDR S&P Pharmaceuticals ETF has a 1 year low of $38.06 and a 1 year high of $48.76. The company’s 50-day moving average is $45.95 and its two-hundred day moving average is $43.44.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.